

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mannose metabolic process (GO:0006013) | 5.08908654 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.99863324 |
| 3 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.66080381 |
| 4 | negative regulation of cell killing (GO:0031342) | 3.64852798 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.64852798 |
| 6 | apoptotic process involved in morphogenesis (GO:0060561) | 3.46704174 |
| 7 | positive thymic T cell selection (GO:0045059) | 3.43925068 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41816570 |
| 9 | cell-cell junction maintenance (GO:0045217) | 3.37622840 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.36549081 |
| 11 | signal complex assembly (GO:0007172) | 3.31025948 |
| 12 | positive regulation of histone deacetylation (GO:0031065) | 3.28103828 |
| 13 | histone H4 deacetylation (GO:0070933) | 3.26438309 |
| 14 | synaptic vesicle maturation (GO:0016188) | 3.26056817 |
| 15 | regulation of ARF protein signal transduction (GO:0032012) | 3.22136115 |
| 16 | locomotory exploration behavior (GO:0035641) | 3.21262052 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.20082721 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.14862439 |
| 19 | sodium ion export (GO:0071436) | 3.13068010 |
| 20 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.11292863 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10828240 |
| 22 | detection of bacterium (GO:0016045) | 3.10783103 |
| 23 | semaphorin-plexin signaling pathway (GO:0071526) | 3.08355394 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.07017338 |
| 25 | thymic T cell selection (GO:0045061) | 3.06203312 |
| 26 | activation of Rac GTPase activity (GO:0032863) | 3.04762970 |
| 27 | modulation by virus of host process (GO:0019054) | 3.03366920 |
| 28 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.98175794 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 2.95991347 |
| 30 | cell communication by electrical coupling (GO:0010644) | 2.94817583 |
| 31 | detection of other organism (GO:0098543) | 2.94398249 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 2.94227106 |
| 33 | carnitine shuttle (GO:0006853) | 2.93717716 |
| 34 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.91730223 |
| 35 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.91666820 |
| 36 | response to peptidoglycan (GO:0032494) | 2.91210544 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 2.91092908 |
| 38 | negative regulation of myotube differentiation (GO:0010832) | 2.90535040 |
| 39 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.90294034 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88433583 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 2.88433583 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88433583 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 2.88433583 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88433583 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88433583 |
| 46 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.85555252 |
| 47 | lysine catabolic process (GO:0006554) | 2.85487630 |
| 48 | lysine metabolic process (GO:0006553) | 2.85487630 |
| 49 | layer formation in cerebral cortex (GO:0021819) | 2.83351322 |
| 50 | activation of protein kinase A activity (GO:0034199) | 2.81162163 |
| 51 | mitochondrion transport along microtubule (GO:0047497) | 2.80773345 |
| 52 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.80773345 |
| 53 | response to muramyl dipeptide (GO:0032495) | 2.80104009 |
| 54 | alpha-linolenic acid metabolic process (GO:0036109) | 2.79700049 |
| 55 | modulation by symbiont of host cellular process (GO:0044068) | 2.79492081 |
| 56 | cellular response to virus (GO:0098586) | 2.79211138 |
| 57 | cellular potassium ion homeostasis (GO:0030007) | 2.78768546 |
| 58 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78666792 |
| 59 | positive regulation of protein deacetylation (GO:0090312) | 2.77172370 |
| 60 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.75282679 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.73876162 |
| 62 | fatty acid transmembrane transport (GO:1902001) | 2.73520676 |
| 63 | protein localization to endosome (GO:0036010) | 2.73495229 |
| 64 | GDP-mannose metabolic process (GO:0019673) | 2.73122926 |
| 65 | activation of JUN kinase activity (GO:0007257) | 2.71682073 |
| 66 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.71649209 |
| 67 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.71295839 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.69773733 |
| 69 | L-phenylalanine metabolic process (GO:0006558) | 2.69773733 |
| 70 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.67048878 |
| 71 | regulation of leukocyte degranulation (GO:0043300) | 2.66307539 |
| 72 | barbed-end actin filament capping (GO:0051016) | 2.66112240 |
| 73 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.66036165 |
| 74 | positive regulation of protein dephosphorylation (GO:0035307) | 2.64267190 |
| 75 | plasma membrane repair (GO:0001778) | 2.63330515 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 2.62562265 |
| 77 | retrograde transport, endosome to Golgi (GO:0042147) | 2.62541742 |
| 78 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.61438040 |
| 79 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.61172026 |
| 80 | histone H3 deacetylation (GO:0070932) | 2.61062619 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.59413329 |
| 82 | L-phenylalanine catabolic process (GO:0006559) | 2.59413329 |
| 83 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.57953106 |
| 84 | proline biosynthetic process (GO:0006561) | 2.57378923 |
| 85 | potassium ion import (GO:0010107) | 2.56470706 |
| 86 | glutamate secretion (GO:0014047) | 2.55741691 |
| 87 | cell communication involved in cardiac conduction (GO:0086065) | 2.55440904 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 2.55399276 |
| 89 | synaptic vesicle exocytosis (GO:0016079) | 2.55381393 |
| 90 | adherens junction assembly (GO:0034333) | 2.55019731 |
| 91 | cell-substrate adherens junction assembly (GO:0007045) | 2.53821182 |
| 92 | focal adhesion assembly (GO:0048041) | 2.53821182 |
| 93 | endothelial cell chemotaxis (GO:0035767) | 2.53563158 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 2.53355790 |
| 95 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.53350024 |
| 96 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.52113958 |
| 97 | regulation of mast cell degranulation (GO:0043304) | 2.51669480 |
| 98 | macrophage activation involved in immune response (GO:0002281) | 2.51521437 |
| 99 | activation of MAPKKK activity (GO:0000185) | 2.50469135 |
| 100 | regulation of necrotic cell death (GO:0010939) | 2.49899578 |
| 101 | vocalization behavior (GO:0071625) | 2.49597176 |
| 102 | dicarboxylic acid catabolic process (GO:0043649) | 2.49325577 |
| 103 | gamma-aminobutyric acid transport (GO:0015812) | 2.48178622 |
| 104 | tricarboxylic acid cycle (GO:0006099) | 2.48141925 |
| 105 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.47995460 |
| 106 | positive regulation of receptor recycling (GO:0001921) | 2.47669317 |
| 107 | neuromuscular process controlling posture (GO:0050884) | 2.47429847 |
| 108 | negative regulation of granulocyte differentiation (GO:0030853) | 2.47250772 |
| 109 | glutamate metabolic process (GO:0006536) | 2.46733289 |
| 110 | cellular ketone body metabolic process (GO:0046950) | 2.45423237 |
| 111 | cell junction maintenance (GO:0034331) | 2.44824481 |
| 112 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.44324311 |
| 113 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.42740845 |
| 114 | negative regulation of viral release from host cell (GO:1902187) | 2.42613956 |
| 115 | positive regulation of myotube differentiation (GO:0010831) | 2.42548154 |
| 116 | amino-acid betaine transport (GO:0015838) | 2.42358939 |
| 117 | carnitine transport (GO:0015879) | 2.42358939 |
| 118 | regulation of regulated secretory pathway (GO:1903305) | 2.42053507 |
| 119 | regulation of necroptotic process (GO:0060544) | 2.41624953 |
| 120 | regulation of fatty acid oxidation (GO:0046320) | 2.41587106 |
| 121 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.41454628 |
| 122 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.40858196 |
| 123 | regulation of defense response to virus by virus (GO:0050690) | 2.40581007 |
| 124 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.40394754 |
| 125 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.40358827 |
| 126 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.39722224 |
| 127 | neurotransmitter secretion (GO:0007269) | 2.39427129 |
| 128 | fatty acid beta-oxidation (GO:0006635) | 2.39266690 |
| 129 | neuromuscular process controlling balance (GO:0050885) | 2.38627254 |
| 130 | short-chain fatty acid metabolic process (GO:0046459) | 2.38235063 |
| 131 | cerebellar Purkinje cell layer development (GO:0021680) | 2.37590963 |
| 132 | carnitine transmembrane transport (GO:1902603) | 2.37258203 |
| 133 | apoptotic process involved in development (GO:1902742) | 2.37175651 |
| 134 | establishment of mitochondrion localization (GO:0051654) | 2.36715204 |
| 135 | actin filament polymerization (GO:0030041) | 2.36030779 |
| 136 | regulation of synapse structural plasticity (GO:0051823) | 2.35382810 |
| 137 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.34770484 |
| 138 | maternal placenta development (GO:0001893) | 2.34152586 |
| 139 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.33051335 |
| 140 | negative regulation of cell size (GO:0045792) | 2.32977198 |
| 141 | regulation of extracellular matrix disassembly (GO:0010715) | 2.32647997 |
| 142 | membrane tubulation (GO:0097320) | 2.32545014 |
| 143 | UV protection (GO:0009650) | 2.32410779 |
| 144 | cellular sodium ion homeostasis (GO:0006883) | 2.32311911 |
| 145 | detection of external biotic stimulus (GO:0098581) | 2.32172798 |
| 146 | glyoxylate metabolic process (GO:0046487) | 2.31559412 |
| 147 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.31152297 |
| 148 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.31021834 |
| 149 | viral protein processing (GO:0019082) | 2.30337463 |
| 150 | adenosine receptor signaling pathway (GO:0001973) | 2.30272954 |
| 151 | protein kinase C signaling (GO:0070528) | 2.29859961 |
| 152 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.29774388 |
| 153 | positive regulation of Rap GTPase activity (GO:0032854) | 2.28413102 |
| 154 | proline metabolic process (GO:0006560) | 2.28377461 |
| 155 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.28322725 |
| 156 | negative regulation of innate immune response (GO:0045824) | 2.28187698 |
| 157 | regulation of synaptic vesicle transport (GO:1902803) | 2.27915354 |
| 158 | regulation of ARF GTPase activity (GO:0032312) | 2.27424791 |
| 159 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.26826808 |
| 160 | succinate metabolic process (GO:0006105) | 2.26168410 |
| 161 | exploration behavior (GO:0035640) | 2.24772041 |
| 162 | cellular modified amino acid catabolic process (GO:0042219) | 2.24018150 |
| 163 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.23517383 |
| 164 | positive regulation of fatty acid oxidation (GO:0046321) | 2.23423083 |
| 165 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.22834002 |
| 166 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.22442933 |
| 167 | glycogen catabolic process (GO:0005980) | 2.22220074 |
| 168 | alanine transport (GO:0032328) | 2.21107746 |
| 169 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.20660154 |
| 170 | membrane repolarization (GO:0086009) | 2.19467914 |
| 171 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.19179096 |
| 172 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.19068529 |
| 173 | fatty acid catabolic process (GO:0009062) | 2.18788865 |
| 174 | protein retention in ER lumen (GO:0006621) | 2.18470130 |
| 175 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.17096412 |
| 176 | cardiac muscle contraction (GO:0060048) | 2.16680023 |
| 177 | cysteine metabolic process (GO:0006534) | 2.16673687 |
| 178 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.16428452 |
| 179 | 4-hydroxyproline metabolic process (GO:0019471) | 2.16000417 |
| 180 | glycine transport (GO:0015816) | 2.15638458 |
| 181 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.14341806 |
| 182 | ketone body metabolic process (GO:1902224) | 2.13876676 |
| 183 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.13632107 |
| 184 | stress fiber assembly (GO:0043149) | 2.13280106 |
| 185 | cell migration in hindbrain (GO:0021535) | 2.12975367 |
| 186 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.12469094 |
| 187 | macroautophagy (GO:0016236) | 2.12292892 |
| 188 | neuronal action potential propagation (GO:0019227) | 2.12114010 |
| 189 | tricarboxylic acid metabolic process (GO:0072350) | 2.10659923 |
| 190 | creatine metabolic process (GO:0006600) | 2.10291303 |
| 191 | glucan catabolic process (GO:0009251) | 2.10092943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.07243632 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.80155963 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.66896686 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.48988685 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.48302934 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38911001 |
| 7 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.38623371 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.31286932 |
| 9 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26900502 |
| 10 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.14875325 |
| 11 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.14461968 |
| 12 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.10308235 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.05108875 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.03342064 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.01512858 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.98384302 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96710142 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92149069 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89095591 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.87484501 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85882233 |
| 22 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.82656560 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75121754 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72498605 |
| 25 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72104772 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70860273 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.69941805 |
| 28 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.69315136 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68738057 |
| 30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.68623869 |
| 31 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67517915 |
| 32 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.66360970 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.64911694 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64753095 |
| 35 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.64411080 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61776417 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60784060 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.60251029 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.59443925 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59245703 |
| 41 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.58683297 |
| 42 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57697316 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55142010 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55142010 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54789652 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54633443 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.52455234 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52268638 |
| 49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51601337 |
| 50 | * MAF_26560356_Chip-Seq_TH1_Human | 1.50932017 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49727665 |
| 52 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.47705865 |
| 53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.45596055 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43180197 |
| 55 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.40758848 |
| 56 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39601298 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36669060 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36112269 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35894833 |
| 60 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.35352726 |
| 61 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.35147390 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34936929 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34852380 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33871967 |
| 65 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.30816590 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30797236 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30039099 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30016878 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29947673 |
| 70 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.29765620 |
| 71 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.28685152 |
| 72 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.28166511 |
| 73 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27803055 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27521693 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24527239 |
| 76 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24039370 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24038580 |
| 78 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22906997 |
| 79 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22460155 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22451796 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19610055 |
| 82 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18432245 |
| 83 | SA1_27219007_Chip-Seq_Bcells_Human | 1.17388356 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.16226262 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16016576 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15922369 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15831714 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15585565 |
| 89 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15479521 |
| 90 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.15274727 |
| 91 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.15079328 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15012283 |
| 93 | P68_20966046_ChIP-Seq_HELA_Human | 1.14950960 |
| 94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.14756665 |
| 95 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14713843 |
| 96 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14647419 |
| 97 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12543438 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12537643 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12537643 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12456848 |
| 101 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11770536 |
| 102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11480149 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11225432 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11208864 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10288327 |
| 106 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10254491 |
| 107 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09732942 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08433130 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07618218 |
| 110 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07427403 |
| 111 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07357674 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06869162 |
| 113 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06399612 |
| 114 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.05837857 |
| 115 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05397813 |
| 116 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05295639 |
| 117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04843864 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04680651 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03843391 |
| 120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03828455 |
| 121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.02705784 |
| 122 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01717663 |
| 123 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.01246323 |
| 124 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.01030305 |
| 125 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00739732 |
| 126 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00373475 |
| 127 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00105054 |
| 128 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00007451 |
| 129 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99988651 |
| 130 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99012883 |
| 131 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99008064 |
| 132 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97846594 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97753298 |
| 134 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97170367 |
| 135 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96121191 |
| 136 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95442457 |
| 137 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94815680 |
| 138 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94501091 |
| 139 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94227712 |
| 140 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93533230 |
| 141 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92650206 |
| 142 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92209147 |
| 143 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91716831 |
| 144 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91678598 |
| 145 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91335927 |
| 146 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91082661 |
| 147 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90610975 |
| 148 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90577867 |
| 149 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89423719 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89148520 |
| 151 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.88937272 |
| 152 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88519169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.73349928 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.63638803 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.39260675 |
| 4 | MP0009278_abnormal_bone_marrow | 3.25467573 |
| 5 | MP0003436_decreased_susceptibility_to | 3.19823306 |
| 6 | MP0008260_abnormal_autophagy | 3.17500543 |
| 7 | MP0005451_abnormal_body_composition | 3.06066031 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.99928209 |
| 9 | MP0000751_myopathy | 2.93442479 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.68767451 |
| 11 | MP0003303_peritoneal_inflammation | 2.55546333 |
| 12 | MP0005360_urolithiasis | 2.52679876 |
| 13 | MP0004130_abnormal_muscle_cell | 2.38357273 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.36971723 |
| 15 | MP0001849_ear_inflammation | 2.27421615 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.23529898 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.23224286 |
| 18 | MP0005365_abnormal_bile_salt | 2.19178109 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.16960635 |
| 20 | MP0003329_amyloid_beta_deposits | 2.16352821 |
| 21 | MP0002249_abnormal_larynx_morphology | 2.13481356 |
| 22 | MP0004233_abnormal_muscle_weight | 2.12774355 |
| 23 | MP0003283_abnormal_digestive_organ | 2.07444727 |
| 24 | MP0004270_analgesia | 2.03336073 |
| 25 | MP0004043_abnormal_pH_regulation | 1.96872667 |
| 26 | MP0005076_abnormal_cell_differentiation | 1.95126571 |
| 27 | MP0002822_catalepsy | 1.79267851 |
| 28 | MP0004858_abnormal_nervous_system | 1.71045089 |
| 29 | MP0000678_abnormal_parathyroid_gland | 1.69366973 |
| 30 | MP0003646_muscle_fatigue | 1.68779993 |
| 31 | MP0004381_abnormal_hair_follicle | 1.66695831 |
| 32 | MP0002063_abnormal_learning/memory/cond | 1.66466399 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.64996458 |
| 34 | MP0002064_seizures | 1.62552953 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.62019832 |
| 36 | MP0005025_abnormal_response_to | 1.60593639 |
| 37 | MP0002419_abnormal_innate_immunity | 1.59477333 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.58330517 |
| 39 | MP0000747_muscle_weakness | 1.58083741 |
| 40 | MP0004145_abnormal_muscle_electrophysio | 1.57165582 |
| 41 | MP0008961_abnormal_basal_metabolism | 1.56692955 |
| 42 | MP0001348_abnormal_lacrimal_gland | 1.55249366 |
| 43 | MP0000685_abnormal_immune_system | 1.55158921 |
| 44 | MP0004947_skin_inflammation | 1.54965104 |
| 45 | MP0002269_muscular_atrophy | 1.52907751 |
| 46 | MP0003195_calcinosis | 1.50456752 |
| 47 | MP0005332_abnormal_amino_acid | 1.50065890 |
| 48 | MP0004510_myositis | 1.49834829 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.49536270 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.49517097 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.48915713 |
| 52 | MP0005409_darkened_coat_color | 1.48640618 |
| 53 | MP0003252_abnormal_bile_duct | 1.45618142 |
| 54 | MP0004087_abnormal_muscle_fiber | 1.45312773 |
| 55 | MP0005330_cardiomyopathy | 1.44785794 |
| 56 | MP0009745_abnormal_behavioral_response | 1.43444561 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.41633386 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39586788 |
| 59 | MP0003137_abnormal_impulse_conducting | 1.37615234 |
| 60 | MP0002933_joint_inflammation | 1.37005206 |
| 61 | MP0003724_increased_susceptibility_to | 1.36964731 |
| 62 | MP0009046_muscle_twitch | 1.35543819 |
| 63 | MP0004885_abnormal_endolymph | 1.35124973 |
| 64 | MP0009840_abnormal_foam_cell | 1.34381461 |
| 65 | MP0001958_emphysema | 1.32348817 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.31442539 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.31442539 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.31344895 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.30233968 |
| 70 | MP0005387_immune_system_phenotype | 1.30166994 |
| 71 | MP0001790_abnormal_immune_system | 1.30166994 |
| 72 | MP0000858_altered_metastatic_potential | 1.28687159 |
| 73 | MP0003279_aneurysm | 1.28185030 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.28080306 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 1.27980253 |
| 76 | MP0001873_stomach_inflammation | 1.27658649 |
| 77 | MP0003633_abnormal_nervous_system | 1.26839820 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 1.26075292 |
| 79 | MP0000749_muscle_degeneration | 1.25649046 |
| 80 | MP0002272_abnormal_nervous_system | 1.25458299 |
| 81 | MP0004215_abnormal_myocardial_fiber | 1.24567379 |
| 82 | MP0005410_abnormal_fertilization | 1.22844541 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.20361532 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 1.20132880 |
| 85 | MP0005083_abnormal_biliary_tract | 1.19771542 |
| 86 | MP0009333_abnormal_splenocyte_physiolog | 1.19117379 |
| 87 | MP0002733_abnormal_thermal_nociception | 1.19059605 |
| 88 | MP0008569_lethality_at_weaning | 1.18663355 |
| 89 | MP0005375_adipose_tissue_phenotype | 1.17623177 |
| 90 | MP0010155_abnormal_intestine_physiology | 1.16901191 |
| 91 | MP0001819_abnormal_immune_cell | 1.16842159 |
| 92 | MP0002420_abnormal_adaptive_immunity | 1.16825591 |
| 93 | MP0003880_abnormal_central_pattern | 1.16801669 |
| 94 | MP0002723_abnormal_immune_serum | 1.14670785 |
| 95 | MP0000003_abnormal_adipose_tissue | 1.12163167 |
| 96 | MP0002132_abnormal_respiratory_system | 1.11293153 |
| 97 | MP0001800_abnormal_humoral_immune | 1.10381591 |
| 98 | MP0003763_abnormal_thymus_physiology | 1.09843530 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 1.07612728 |
| 100 | MP0005670_abnormal_white_adipose | 1.07081107 |
| 101 | MP0000759_abnormal_skeletal_muscle | 1.06952776 |
| 102 | MP0005620_abnormal_muscle_contractility | 1.05019718 |
| 103 | MP0000955_abnormal_spinal_cord | 1.04746190 |
| 104 | MP0005623_abnormal_meninges_morphology | 1.03192303 |
| 105 | MP0001970_abnormal_pain_threshold | 1.02623517 |
| 106 | MP0003075_altered_response_to | 1.01746401 |
| 107 | MP0003878_abnormal_ear_physiology | 1.01571469 |
| 108 | MP0005377_hearing/vestibular/ear_phenot | 1.01571469 |
| 109 | MP0003866_abnormal_defecation | 1.01379056 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.99953463 |
| 111 | MP0002452_abnormal_antigen_presenting | 0.99436557 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.99091286 |
| 113 | MP0005390_skeleton_phenotype | 0.98775507 |
| 114 | MP0000604_amyloidosis | 0.98488693 |
| 115 | MP0002106_abnormal_muscle_physiology | 0.97028467 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.96970643 |
| 117 | MP0001835_abnormal_antigen_presentation | 0.95812910 |
| 118 | MP0002734_abnormal_mechanical_nocicepti | 0.95596706 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.94699678 |
| 120 | MP0003690_abnormal_glial_cell | 0.94186888 |
| 121 | MP0001666_abnormal_nutrient_absorption | 0.94070432 |
| 122 | MP0004811_abnormal_neuron_physiology | 0.94036255 |
| 123 | MP0003879_abnormal_hair_cell | 0.93429302 |
| 124 | MP0004085_abnormal_heartbeat | 0.93042281 |
| 125 | MP0000750_abnormal_muscle_regeneration | 0.92785345 |
| 126 | MP0005535_abnormal_body_temperature | 0.92720214 |
| 127 | MP0000716_abnormal_immune_system | 0.92341546 |
| 128 | MP0001440_abnormal_grooming_behavior | 0.92211861 |
| 129 | MP0003045_fibrosis | 0.92189205 |
| 130 | MP0002066_abnormal_motor_capabilities/c | 0.92095427 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.90977522 |
| 132 | MP0001968_abnormal_touch/_nociception | 0.89087044 |
| 133 | MP0002971_abnormal_brown_adipose | 0.88836381 |
| 134 | MP0010630_abnormal_cardiac_muscle | 0.88675386 |
| 135 | MP0003634_abnormal_glial_cell | 0.88179958 |
| 136 | MP0001486_abnormal_startle_reflex | 0.86652285 |
| 137 | MP0008874_decreased_physiological_sensi | 0.86098828 |
| 138 | MP0003631_nervous_system_phenotype | 0.85886015 |
| 139 | MP0006082_CNS_inflammation | 0.85640113 |
| 140 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85558443 |
| 141 | MP0000579_abnormal_nail_morphology | 0.84334675 |
| 142 | MP0005464_abnormal_platelet_physiology | 0.84176948 |
| 143 | MP0002398_abnormal_bone_marrow | 0.84165337 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.83476081 |
| 145 | MP0002653_abnormal_ependyma_morphology | 0.82556821 |
| 146 | MP0002972_abnormal_cardiac_muscle | 0.81973748 |
| 147 | MP0005369_muscle_phenotype | 0.81933869 |
| 148 | MP0002067_abnormal_sensory_capabilities | 0.81374970 |
| 149 | MP0000534_abnormal_ureter_morphology | 0.80925608 |
| 150 | MP0000920_abnormal_myelination | 0.80774480 |
| 151 | MP0003091_abnormal_cell_migration | 0.80745417 |
| 152 | MP0002234_abnormal_pharynx_morphology | 0.80077072 |
| 153 | MP0003300_gastrointestinal_ulcer | 0.79758657 |
| 154 | MP0004924_abnormal_behavior | 0.79713803 |
| 155 | MP0005386_behavior/neurological_phenoty | 0.79713803 |
| 156 | MP0006036_abnormal_mitochondrial_physio | 0.77341278 |
| 157 | MP0002429_abnormal_blood_cell | 0.77022305 |
| 158 | MP0001663_abnormal_digestive_system | 0.76170506 |
| 159 | MP0002405_respiratory_system_inflammati | 0.76166137 |
| 160 | MP0005423_abnormal_somatic_nervous | 0.75688345 |
| 161 | MP0000733_abnormal_muscle_development | 0.75270539 |
| 162 | MP0001502_abnormal_circadian_rhythm | 0.75249031 |
| 163 | MP0003191_abnormal_cellular_cholesterol | 0.74714432 |
| 164 | MP0002882_abnormal_neuron_morphology | 0.74075199 |
| 165 | MP0002148_abnormal_hypersensitivity_rea | 0.74070562 |
| 166 | MP0000703_abnormal_thymus_morphology | 0.73946760 |
| 167 | MP0003566_abnormal_cell_adhesion | 0.71921040 |
| 168 | MP0002254_reproductive_system_inflammat | 0.71496127 |
| 169 | MP0010030_abnormal_orbit_morphology | 0.70137151 |
| 170 | MP0005501_abnormal_skin_physiology | 0.68549258 |
| 171 | MP0001845_abnormal_inflammatory_respons | 0.67360578 |
| 172 | MP0003123_paternal_imprinting | 0.67352002 |
| 173 | MP0002722_abnormal_immune_system | 0.66950986 |
| 174 | MP0009931_abnormal_skin_appearance | 0.66750575 |
| 175 | MP0005166_decreased_susceptibility_to | 0.66029293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 3.89731622 |
| 2 | Obstructive sleep apnea (HP:0002870) | 3.88985668 |
| 3 | Myokymia (HP:0002411) | 3.52962570 |
| 4 | Ketoacidosis (HP:0001993) | 3.51769059 |
| 5 | Broad face (HP:0000283) | 3.41755241 |
| 6 | Myoglobinuria (HP:0002913) | 3.18523690 |
| 7 | Stridor (HP:0010307) | 3.13876161 |
| 8 | Ketosis (HP:0001946) | 3.09003408 |
| 9 | Sudden death (HP:0001699) | 3.06214837 |
| 10 | Hyperacusis (HP:0010780) | 3.02195374 |
| 11 | Eczematoid dermatitis (HP:0000976) | 2.97897848 |
| 12 | Cervical subluxation (HP:0003308) | 2.97815722 |
| 13 | J-shaped sella turcica (HP:0002680) | 2.94278808 |
| 14 | Turricephaly (HP:0000262) | 2.94227774 |
| 15 | Bundle branch block (HP:0011710) | 2.81142807 |
| 16 | Gout (HP:0001997) | 2.73484770 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 2.71153767 |
| 18 | Metaphyseal cupping (HP:0003021) | 2.70338499 |
| 19 | Thin bony cortex (HP:0002753) | 2.66825254 |
| 20 | Pheochromocytoma (HP:0002666) | 2.66820509 |
| 21 | Exercise-induced muscle cramps (HP:0003710) | 2.63764652 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 2.63300527 |
| 23 | Abnormality of the lower motor neuron (HP:0002366) | 2.63117565 |
| 24 | Dysostosis multiplex (HP:0000943) | 2.61110703 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 2.59356307 |
| 26 | Hyperthyroidism (HP:0000836) | 2.59222063 |
| 27 | Cerebral inclusion bodies (HP:0100314) | 2.55697702 |
| 28 | Hyporeflexia of lower limbs (HP:0002600) | 2.54085666 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.53296120 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51147185 |
| 31 | Obstructive lung disease (HP:0006536) | 2.51147185 |
| 32 | Easy fatigability (HP:0003388) | 2.50675819 |
| 33 | Myopathic facies (HP:0002058) | 2.48994060 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48732319 |
| 35 | Large for gestational age (HP:0001520) | 2.47649925 |
| 36 | Visual hallucinations (HP:0002367) | 2.46545612 |
| 37 | Neurofibrillary tangles (HP:0002185) | 2.44578048 |
| 38 | Colitis (HP:0002583) | 2.43546352 |
| 39 | Vertebral compression fractures (HP:0002953) | 2.43398297 |
| 40 | Hypertensive crisis (HP:0100735) | 2.41230866 |
| 41 | Ulnar bowing (HP:0003031) | 2.40799876 |
| 42 | Increased IgE level (HP:0003212) | 2.40620349 |
| 43 | Cellulitis (HP:0100658) | 2.39177542 |
| 44 | Increased connective tissue (HP:0009025) | 2.39029669 |
| 45 | Abnormality of the Achilles tendon (HP:0005109) | 2.38152923 |
| 46 | Joint stiffness (HP:0001387) | 2.37803128 |
| 47 | Difficulty running (HP:0009046) | 2.37548004 |
| 48 | Biconcave vertebral bodies (HP:0004586) | 2.36078767 |
| 49 | Hypercortisolism (HP:0001578) | 2.34485825 |
| 50 | Truncus arteriosus (HP:0001660) | 2.33897232 |
| 51 | Deep venous thrombosis (HP:0002625) | 2.28897274 |
| 52 | Achilles tendon contracture (HP:0001771) | 2.28053385 |
| 53 | Atelectasis (HP:0100750) | 2.27470872 |
| 54 | Xanthomatosis (HP:0000991) | 2.27079916 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.26471634 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.25956198 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.25860354 |
| 58 | Late onset (HP:0003584) | 2.23655747 |
| 59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22567106 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22567106 |
| 61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22567106 |
| 62 | Recurrent abscess formation (HP:0002722) | 2.22168649 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.22097969 |
| 64 | Focal motor seizures (HP:0011153) | 2.22069117 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.21772418 |
| 66 | Neuroendocrine neoplasm (HP:0100634) | 2.21126466 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.20456847 |
| 68 | Cholecystitis (HP:0001082) | 2.20456847 |
| 69 | Flattened epiphyses (HP:0003071) | 2.20359086 |
| 70 | Hypochromic anemia (HP:0001931) | 2.18601342 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.17807025 |
| 72 | Distal upper limb amyotrophy (HP:0007149) | 2.17679910 |
| 73 | Upper limb amyotrophy (HP:0009129) | 2.17679910 |
| 74 | Global brain atrophy (HP:0002283) | 2.17197639 |
| 75 | Annular pancreas (HP:0001734) | 2.17045789 |
| 76 | Action tremor (HP:0002345) | 2.16963540 |
| 77 | Cerebral aneurysm (HP:0004944) | 2.15675342 |
| 78 | Hypoglycemic coma (HP:0001325) | 2.13780835 |
| 79 | Mucopolysacchariduria (HP:0008155) | 2.13117044 |
| 80 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13117044 |
| 81 | Myotonia (HP:0002486) | 2.11887975 |
| 82 | Polygenic inheritance (HP:0010982) | 2.10959471 |
| 83 | Hyperglycinuria (HP:0003108) | 2.10409740 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09994165 |
| 85 | Dysmetric saccades (HP:0000641) | 2.08305054 |
| 86 | Heart block (HP:0012722) | 2.08246415 |
| 87 | Hyperammonemia (HP:0001987) | 2.07907461 |
| 88 | Focal seizures (HP:0007359) | 2.05873642 |
| 89 | Abnormality of the thoracic spine (HP:0100711) | 2.05642255 |
| 90 | Resting tremor (HP:0002322) | 2.05505976 |
| 91 | Increased serum ferritin (HP:0003281) | 2.04154766 |
| 92 | Flat acetabular roof (HP:0003180) | 2.03984582 |
| 93 | Hypertriglyceridemia (HP:0002155) | 2.03511977 |
| 94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03407690 |
| 95 | Muscle fiber splitting (HP:0003555) | 2.03207556 |
| 96 | Recurrent bacterial skin infections (HP:0005406) | 2.03125279 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 2.03090428 |
| 98 | Abnormality of glycine metabolism (HP:0010895) | 2.02554699 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.02554699 |
| 100 | Depression (HP:0000716) | 2.02276516 |
| 101 | Mitral regurgitation (HP:0001653) | 2.01848008 |
| 102 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01719147 |
| 103 | Broad distal phalanx of finger (HP:0009836) | 2.01536035 |
| 104 | Gingivitis (HP:0000230) | 2.01439258 |
| 105 | Gastrointestinal inflammation (HP:0004386) | 2.01358822 |
| 106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.98682746 |
| 107 | Ankle clonus (HP:0011448) | 1.98556592 |
| 108 | Flat capital femoral epiphysis (HP:0003370) | 1.98066674 |
| 109 | Insidious onset (HP:0003587) | 1.97808956 |
| 110 | Termporal pattern (HP:0011008) | 1.97808956 |
| 111 | Myositis (HP:0100614) | 1.97565499 |
| 112 | Thoracic kyphosis (HP:0002942) | 1.95442971 |
| 113 | Atrioventricular block (HP:0001678) | 1.95161997 |
| 114 | Rapidly progressive (HP:0003678) | 1.95013470 |
| 115 | Seborrheic dermatitis (HP:0001051) | 1.94606916 |
| 116 | Torticollis (HP:0000473) | 1.93297209 |
| 117 | Hamartoma of the eye (HP:0010568) | 1.93014375 |
| 118 | Megalencephaly (HP:0001355) | 1.92899740 |
| 119 | Nuclear cataract (HP:0100018) | 1.91758209 |
| 120 | Abnormal atrioventricular conduction (HP:0005150) | 1.91553235 |
| 121 | Insomnia (HP:0100785) | 1.91071716 |
| 122 | Calf muscle hypertrophy (HP:0008981) | 1.91013653 |
| 123 | Reticulocytosis (HP:0001923) | 1.90549808 |
| 124 | Atonic seizures (HP:0010819) | 1.88334668 |
| 125 | Male infertility (HP:0003251) | 1.87974679 |
| 126 | Anxiety (HP:0000739) | 1.87946081 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87751591 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87751591 |
| 129 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87751591 |
| 130 | Spinal canal stenosis (HP:0003416) | 1.87618061 |
| 131 | Disproportionate tall stature (HP:0001519) | 1.87520123 |
| 132 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.87363581 |
| 133 | Hand muscle atrophy (HP:0009130) | 1.87028782 |
| 134 | Status epilepticus (HP:0002133) | 1.86931528 |
| 135 | Back pain (HP:0003418) | 1.86853343 |
| 136 | Prolonged QT interval (HP:0001657) | 1.86710572 |
| 137 | Lymphangioma (HP:0100764) | 1.86601223 |
| 138 | Abnormality of the nasal mucosa (HP:0000433) | 1.86145778 |
| 139 | Syncope (HP:0001279) | 1.84910118 |
| 140 | Intention tremor (HP:0002080) | 1.84832098 |
| 141 | Nasal polyposis (HP:0100582) | 1.84678012 |
| 142 | Abnormal social behavior (HP:0012433) | 1.84470025 |
| 143 | Impaired social interactions (HP:0000735) | 1.84470025 |
| 144 | Gastrointestinal infarctions (HP:0005244) | 1.84305756 |
| 145 | Abnormality of the calf musculature (HP:0001430) | 1.84232106 |
| 146 | Protrusio acetabuli (HP:0003179) | 1.84115131 |
| 147 | Cholelithiasis (HP:0001081) | 1.82920775 |
| 148 | Focal dystonia (HP:0004373) | 1.82649870 |
| 149 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.82467202 |
| 150 | Bowel incontinence (HP:0002607) | 1.82393491 |
| 151 | Hyperglycinemia (HP:0002154) | 1.82320896 |
| 152 | Urinary urgency (HP:0000012) | 1.82150971 |
| 153 | Postural instability (HP:0002172) | 1.80869213 |
| 154 | Polycythemia (HP:0001901) | 1.80079626 |
| 155 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.79237905 |
| 156 | Difficulty climbing stairs (HP:0003551) | 1.79014223 |
| 157 | Dysdiadochokinesis (HP:0002075) | 1.78912873 |
| 158 | Craniofacial dystonia (HP:0012179) | 1.78150822 |
| 159 | Hyperlipoproteinemia (HP:0010980) | 1.77758205 |
| 160 | Intrahepatic cholestasis (HP:0001406) | 1.77040655 |
| 161 | Abnormal gallbladder morphology (HP:0012437) | 1.76260784 |
| 162 | Purpura (HP:0000979) | 1.75868712 |
| 163 | Loss of speech (HP:0002371) | 1.75704544 |
| 164 | Amyloidosis (HP:0011034) | 1.75270059 |
| 165 | Shallow orbits (HP:0000586) | 1.75003208 |
| 166 | Bulbar palsy (HP:0001283) | 1.74677496 |
| 167 | Ventricular arrhythmia (HP:0004308) | 1.74549008 |
| 168 | Slow saccadic eye movements (HP:0000514) | 1.74316677 |
| 169 | Growth hormone excess (HP:0000845) | 1.74301152 |
| 170 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.74179826 |
| 171 | Long toe (HP:0010511) | 1.73556850 |
| 172 | Muscle stiffness (HP:0003552) | 1.73402119 |
| 173 | Mediastinal lymphadenopathy (HP:0100721) | 1.73084151 |
| 174 | EMG: neuropathic changes (HP:0003445) | 1.72954110 |
| 175 | Increased circulating renin level (HP:0000848) | 1.72742421 |
| 176 | Onion bulb formation (HP:0003383) | 1.72588719 |
| 177 | Pointed chin (HP:0000307) | 1.72499563 |
| 178 | Neonatal onset (HP:0003623) | 1.72206147 |
| 179 | Foot dorsiflexor weakness (HP:0009027) | 1.71818504 |
| 180 | Inflammation of the large intestine (HP:0002037) | 1.71346219 |
| 181 | Thin ribs (HP:0000883) | 1.71229361 |
| 182 | Dysmetria (HP:0001310) | 1.69142896 |
| 183 | Athetosis (HP:0002305) | 1.68183217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.72996751 |
| 2 | ICK | 3.00049432 |
| 3 | PRKD3 | 2.76728123 |
| 4 | SMG1 | 2.61397998 |
| 5 | PHKG2 | 2.28735700 |
| 6 | PHKG1 | 2.28735700 |
| 7 | MAP2K3 | 2.23336332 |
| 8 | TNK2 | 2.14305843 |
| 9 | DDR2 | 2.12479422 |
| 10 | PINK1 | 2.07336516 |
| 11 | MAP4K1 | 2.03195297 |
| 12 | PKN2 | 2.00096739 |
| 13 | EPHA4 | 1.99948581 |
| 14 | PDK4 | 1.97666149 |
| 15 | PDK3 | 1.97666149 |
| 16 | MAP3K9 | 1.96545019 |
| 17 | LMTK2 | 1.95720350 |
| 18 | TYRO3 | 1.85586355 |
| 19 | RIPK4 | 1.76694974 |
| 20 | PDGFRA | 1.75300463 |
| 21 | WNK4 | 1.71234609 |
| 22 | MAPK15 | 1.70719605 |
| 23 | KSR2 | 1.68892444 |
| 24 | NTRK3 | 1.64842308 |
| 25 | DAPK2 | 1.64672008 |
| 26 | UHMK1 | 1.56985782 |
| 27 | EPHA2 | 1.55821647 |
| 28 | TTN | 1.55246704 |
| 29 | PAK6 | 1.51440689 |
| 30 | BCKDK | 1.50385632 |
| 31 | RIPK1 | 1.45133942 |
| 32 | STK38 | 1.42978235 |
| 33 | NTRK1 | 1.42755431 |
| 34 | MAP3K4 | 1.35137413 |
| 35 | NME2 | 1.34656409 |
| 36 | TESK2 | 1.31431613 |
| 37 | BLK | 1.25933744 |
| 38 | PRKD2 | 1.25171427 |
| 39 | SIK1 | 1.19576102 |
| 40 | IRAK3 | 1.19561278 |
| 41 | MAP3K7 | 1.16368594 |
| 42 | CAMKK1 | 1.16141795 |
| 43 | MAP3K2 | 1.14058253 |
| 44 | DMPK | 1.13646006 |
| 45 | TBK1 | 1.13501918 |
| 46 | BMX | 1.11700005 |
| 47 | MAP3K6 | 1.11547492 |
| 48 | DAPK1 | 1.09982614 |
| 49 | MINK1 | 1.09745711 |
| 50 | ZAP70 | 1.08131781 |
| 51 | FGFR4 | 1.06780214 |
| 52 | TYK2 | 1.06628871 |
| 53 | TAOK1 | 1.06272011 |
| 54 | GRK6 | 1.04581999 |
| 55 | ERN1 | 1.03076270 |
| 56 | WNK3 | 0.99467237 |
| 57 | DYRK1B | 0.99407788 |
| 58 | RPS6KC1 | 0.99095518 |
| 59 | RPS6KL1 | 0.99095518 |
| 60 | MAP3K13 | 0.99052382 |
| 61 | RPS6KA2 | 0.98915944 |
| 62 | MAP2K4 | 0.97663492 |
| 63 | MAP3K3 | 0.97107440 |
| 64 | LATS2 | 0.96645967 |
| 65 | RET | 0.96105645 |
| 66 | IRAK4 | 0.95843792 |
| 67 | MARK1 | 0.95497564 |
| 68 | MAPK12 | 0.93978635 |
| 69 | MAP2K6 | 0.93376031 |
| 70 | FES | 0.92044710 |
| 71 | CDC42BPA | 0.91684792 |
| 72 | WNK1 | 0.90958601 |
| 73 | PRKCH | 0.90942064 |
| 74 | PDK2 | 0.90833351 |
| 75 | CSK | 0.90513292 |
| 76 | STK39 | 0.86519985 |
| 77 | PTK6 | 0.86098101 |
| 78 | MAP3K11 | 0.85232168 |
| 79 | CDK5 | 0.84892461 |
| 80 | TAOK2 | 0.82469389 |
| 81 | NTRK2 | 0.82445343 |
| 82 | DAPK3 | 0.82433663 |
| 83 | RPS6KA6 | 0.81265303 |
| 84 | PRKD1 | 0.80591412 |
| 85 | PTK2B | 0.80490829 |
| 86 | MAP2K2 | 0.80172697 |
| 87 | SIK3 | 0.79572939 |
| 88 | CDK12 | 0.79306500 |
| 89 | PDPK1 | 0.77858323 |
| 90 | MAP3K10 | 0.77014054 |
| 91 | PAK3 | 0.76786132 |
| 92 | FGR | 0.76614945 |
| 93 | OXSR1 | 0.75148499 |
| 94 | MARK2 | 0.73926580 |
| 95 | MST1R | 0.72732421 |
| 96 | NME1 | 0.72511555 |
| 97 | PTK2 | 0.70077581 |
| 98 | ARAF | 0.68819219 |
| 99 | JAK3 | 0.67961606 |
| 100 | BTK | 0.66303573 |
| 101 | PRKAA1 | 0.65471680 |
| 102 | MAP3K1 | 0.64748904 |
| 103 | SGK223 | 0.64000771 |
| 104 | SGK494 | 0.64000771 |
| 105 | FER | 0.63473553 |
| 106 | PDK1 | 0.63420025 |
| 107 | CAMK2G | 0.62636178 |
| 108 | LRRK2 | 0.62406948 |
| 109 | SIK2 | 0.61488297 |
| 110 | PRPF4B | 0.60332445 |
| 111 | SGK3 | 0.59532413 |
| 112 | CAMK2B | 0.59000466 |
| 113 | CAMK2D | 0.58660846 |
| 114 | HCK | 0.58182366 |
| 115 | CAMK2A | 0.56795663 |
| 116 | EEF2K | 0.56778119 |
| 117 | MAPK11 | 0.54675741 |
| 118 | STK11 | 0.53643188 |
| 119 | CSF1R | 0.53321745 |
| 120 | ILK | 0.51697567 |
| 121 | GRK5 | 0.50843872 |
| 122 | CAMK1G | 0.50730595 |
| 123 | PRKCZ | 0.50426249 |
| 124 | MTOR | 0.48814010 |
| 125 | GSK3A | 0.48285907 |
| 126 | NEK1 | 0.47922524 |
| 127 | INSRR | 0.47480657 |
| 128 | EPHB1 | 0.46333609 |
| 129 | PAK4 | 0.45435056 |
| 130 | SGK1 | 0.45046360 |
| 131 | IKBKB | 0.44169067 |
| 132 | ALK | 0.43447629 |
| 133 | PDGFRB | 0.42964115 |
| 134 | TESK1 | 0.42764811 |
| 135 | PRKG2 | 0.42334123 |
| 136 | FGFR2 | 0.42299280 |
| 137 | ROCK1 | 0.42046589 |
| 138 | MAPK7 | 0.40714246 |
| 139 | CDK15 | 0.40390127 |
| 140 | KSR1 | 0.40045011 |
| 141 | IRAK2 | 0.39619318 |
| 142 | HIPK2 | 0.39295091 |
| 143 | KDR | 0.38666882 |
| 144 | IKBKE | 0.37892004 |
| 145 | RPS6KA1 | 0.37350188 |
| 146 | MAPKAPK3 | 0.37163706 |
| 147 | SYK | 0.37028151 |
| 148 | BRAF | 0.36123604 |
| 149 | MAPK4 | 0.35995825 |
| 150 | JAK2 | 0.35373443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.60404006 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.93797874 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41981526 |
| 4 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.26578273 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18605172 |
| 6 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.17329064 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.13853679 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.10508494 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.02263767 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.98761345 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97272269 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95957337 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.94013135 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89884426 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86865009 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.86809041 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80331772 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.77577417 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75076279 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71056879 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.66034236 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60658901 |
| 23 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.58257289 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55456977 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50188057 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49122252 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.43640560 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42723723 |
| 29 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.40340372 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40125896 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.36030198 |
| 32 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.33981754 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33442963 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33290030 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.32409213 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.30595049 |
| 37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.25163695 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25037134 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23819324 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23651245 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.21585641 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18797192 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16218607 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16119091 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.15151788 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14481612 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13206693 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13090144 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.12489765 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 1.11696178 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.10898374 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09963147 |
| 53 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08054784 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.07492494 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06585356 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 1.05992271 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.05712561 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05615333 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 1.05543607 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04717120 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04231919 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02962922 |
| 63 | Olfactory transduction_Homo sapiens_hsa04740 | 1.02745398 |
| 64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01542329 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00291705 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 1.00214377 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99375163 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98753312 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98293535 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.98095636 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97301561 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.97217506 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97107038 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96653874 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96401350 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95366560 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95228593 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93152826 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91996016 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91895570 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91622152 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91251887 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91244785 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90070403 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87267860 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86687090 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86373250 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86364580 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86205768 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86030475 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.85523610 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.84841934 |
| 93 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.84450164 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81971914 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80921468 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79981596 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79864169 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78662375 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78018756 |
| 100 | Nicotine addiction_Homo sapiens_hsa05033 | 0.77491221 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.76703896 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76533096 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.75468514 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75303896 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75011534 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73322516 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73109266 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72578798 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72526784 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71573273 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71179278 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71039397 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70794712 |
| 114 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70662393 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.70532445 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70271982 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69506171 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.69204982 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68928015 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68276136 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66567697 |
| 122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66495899 |
| 123 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66347454 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65895686 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65771037 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.65338507 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.64825416 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.64549183 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63804051 |
| 130 | Taste transduction_Homo sapiens_hsa04742 | 0.63759421 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63754674 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63697667 |
| 133 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63498561 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62407540 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61801560 |
| 136 | Salmonella infection_Homo sapiens_hsa05132 | 0.61570590 |
| 137 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59979487 |
| 138 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59496518 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59464756 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.59415406 |
| 141 | Glioma_Homo sapiens_hsa05214 | 0.59162123 |
| 142 | Shigellosis_Homo sapiens_hsa05131 | 0.58721729 |
| 143 | Amoebiasis_Homo sapiens_hsa05146 | 0.58221027 |
| 144 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58129625 |
| 145 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57655308 |
| 146 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57583807 |
| 147 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56592288 |
| 148 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56383906 |
| 149 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55492460 |
| 150 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55346066 |
| 151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55249849 |
| 152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54989350 |
| 153 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54890711 |
| 154 | Melanogenesis_Homo sapiens_hsa04916 | 0.54886173 |
| 155 | Platelet activation_Homo sapiens_hsa04611 | 0.54749810 |
| 156 | Focal adhesion_Homo sapiens_hsa04510 | 0.53477768 |
| 157 | Bladder cancer_Homo sapiens_hsa05219 | 0.53199574 |
| 158 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52410031 |
| 159 | Long-term depression_Homo sapiens_hsa04730 | 0.50398050 |
| 160 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50052163 |
| 161 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49887431 |
| 162 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49713427 |
| 163 | Pertussis_Homo sapiens_hsa05133 | 0.49144866 |
| 164 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47067803 |
| 165 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45647861 |
| 166 | Measles_Homo sapiens_hsa05162 | 0.45012421 |
| 167 | ABC transporters_Homo sapiens_hsa02010 | 0.44967745 |
| 168 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44661703 |
| 169 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44485701 |

